Mostrar el registro sencillo del ítem
dc.contributor.author | Girotti ., Alessandra | |
dc.contributor.author | Escalera Anzola, Sara | |
dc.contributor.author | Alonso Sampedro, Irene | |
dc.contributor.author | González Valdivieso, Juan | |
dc.contributor.author | Arias Vallejo, Francisco Javier | |
dc.date.accessioned | 2023-03-02T08:37:49Z | |
dc.date.available | 2023-03-02T08:37:49Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Pharmaceutics, 2020, Vol.12, Nº. 11, 1115 | es |
dc.identifier.issn | 1999-4923 | es |
dc.identifier.uri | https://uvadoc.uva.es/handle/10324/58816 | |
dc.description | Producción Científica | es |
dc.description.abstract | Biomaterials science is one of the most rapidly evolving fields in biomedicine. However, although novel biomaterials have achieved well-defined goals, such as the production of devices with improved biocompatibility and mechanical properties, their development could be more ambitious. Indeed, the integration of active targeting strategies has been shown to allow spatiotemporal control of cell–material interactions, thus leading to more specific and better-performing devices. This manuscript reviews recent advances that have led to enhanced biomaterials resulting from the use of natural structural macromolecules. In this regard, several structural macromolecules have been adapted or modified using biohybrid approaches for use in both regenerative medicine and therapeutic delivery. The integration of structural and functional features and aptamer targeting, although still incipient, has already shown its ability and wide-reaching potential. In this review, we discuss aptamer-functionalized hybrid protein-based or polymeric biomaterials derived from structural macromolecules, with a focus on bioresponsive/bioactive systems. | es |
dc.format.mimetype | application/pdf | es |
dc.language.iso | eng | es |
dc.publisher | MDPI | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Biomaterials | es |
dc.subject | Biomedicina | es |
dc.subject | Biopolymers | es |
dc.subject | Polymers in medicine | es |
dc.subject.classification | Aptamers | es |
dc.title | Aptamer-functionalized natural protein-based polymers as innovative biomaterials | es |
dc.type | info:eu-repo/semantics/article | es |
dc.rights.holder | © 2020 The Authors | es |
dc.identifier.doi | 10.3390/pharmaceutics12111115 | es |
dc.relation.publisherversion | https://www.mdpi.com/1999-4923/12/11/1115 | es |
dc.identifier.publicationfirstpage | 1115 | es |
dc.identifier.publicationissue | 11 | es |
dc.identifier.publicationtitle | Pharmaceutics | es |
dc.identifier.publicationvolume | 12 | es |
dc.peerreviewed | SI | es |
dc.description.project | Ministerio de Economía, Industria y Competitividad - Fondo Europeo de Desarrollo Regional - Fondo Social Europeo (Proyects MAT2016-79435-R, DTS19/00162, and PID2019-106386RB-I00) | es |
dc.description.project | Junta de Castilla y León (Project VA317P18) | es |
dc.identifier.essn | 1999-4923 | es |
dc.rights | Atribución 4.0 Internacional | * |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es |
dc.subject.unesco | 2403 Bioquímica | es |
dc.subject.unesco | 2302.21 Biología Molecular | es |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
La licencia del ítem se describe como Atribución 4.0 Internacional